About the Company
resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TORC News
Buy Rating Affirmed for Adicet Bio Amid Promising CAR T-Cell Therapies and Strong Financial Footing
Soumit Roy, an analyst from JonesTrading, maintained the Buy rating on Adicet Bio (ACET – Research Report). The associated price target ...
Adicet Bio’s Promising Drug Pipeline and Buy Rating Justification
Canaccord Genuity analyst John Newman maintained a Buy rating on Adicet Bio (ACET – Research Report) yesterday and set a price target of ...
Welcome to Inc.'s Directory of B2B Excellence
They all made it through Inc.'s proprietary vetting process, based in part on testimonials from other clients. As any entrepreneur knows, the right partnership can make all the difference.
Sweet Baby Inc. Doesn’t Do What Some Gamers Think It Does
Sweet Baby Inc. is not the largest narrative design company in the games industry. Nor is it solely responsible for the characters and stories in recent high-profile releases like Alan Wake 2 ...
Restorbio Ord Share Chat
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
Starwood Property Trust Inc.
Annaly Capital Management Inc. 6.5% Conv. Pfd. Series G 0.44% Annaly Capital Management Inc. Pfd. Series I 0.32% Annaly Capital Management Inc. 6.95% Cum. Redeem. Pfd. Series F 0.48% ...
STIHL Inc.
This company has paid to receive expanded profile features. About STIHL Inc. Virginia-based STIHL Inc. is the U.S. affiliate for the global STIHL group and the manufacturer of the number one ...
Snap Inc Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
About Inc.com | Everything You Need to Know to Grow and Start Your Business
Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...
P10, Inc. (PX) Stock Price, News, Quote & History - Yahoo Finance
P10 ( NYSE:PX ) Full Year 2023 Results Key Financial Results Revenue: US$241.7m (up 22% from FY 2022). Net loss... P10, Inc. (NYSE:PX) Q4 2023 Earnings Call Transcript February 29, 2024 P10, Inc ...
Apple Inc.
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
Snap Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...